Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Colorectal Neoplasms

Free Subscription 04.02.2019 3 Am J Clin Oncol 1 Ann Oncol 4 Ann Surg Oncol 3 BMC Gastroenterol 4 Br J Cancer 1 Cancer Lett 1 Cancer Res 1 Clin Cancer Res 1 Clin Res Hepatol Gastroenterol 1 Curr Treat Options Oncol 1 Eur J Cancer 2 Eur J Gastroenterol Hepatol 4 Gastroenterology 2 Int J Cancer 2 Int J Colorectal Dis 2 Lancet 1 N Engl J Med 1 Oncogene 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Clin Oncol

1. MCCLURE LA, Sussman DA, Hernandez MN, Tannenbaum SL, et al
   Factors Associated With Receipt of Radiation Therapy for Rectal Cancer.
   Am J Clin Oncol. 2018;41:227-229.
   PubMed     Text format     Abstract available
   
   
2. NGUYEN P, Wuthrick E, Chablani P, Robinson A, et al
   Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience.
   Am J Clin Oncol. 2018;41:140-146.
   PubMed     Text format     Abstract available
   
   
3. DESHMUKH AA, Zhao H, Franzini L, Lairson DR, et al
   Total Lifetime and Cancer-related Costs for Elderly Patients Diagnosed With Anal Cancer in the United States.
   Am J Clin Oncol. 2018;41:121-127.
   PubMed     Text format     Abstract available
   
   

   
   Ann Oncol

4. VIDAL J, Bellosillo B, Santos Vivas C, Garcia-Alfonso P, et al
   Ultra-selection of metastatic colorectal cancer patients using Next Generation Sequencing to improve clinical efficacy of anti-EGFR therapy.
   Ann Oncol. 2019 Jan 23. pii: 5299439. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Ann Surg Oncol

5. HAMILTON TD, MacNeill AJ, Lim H, Hunink MGM, et al
   Cost-Effectiveness Analysis of Cytoreductive Surgery and HIPEC Compared With Systemic Chemotherapy in Isolated Peritoneal Carcinomatosis From Metastatic Colorectal Cancer.
   Ann Surg Oncol. 2019 Jan 28. pii: 10.1245/s10434-018-07111.
   PubMed     Text format     Abstract available
   
   
6. ASARE EA, Vreeland TJ, Feig BW
   Resection of a Perirectal Leiomyosarcoma via a Posterior Transcoccygeal Approach.
   Ann Surg Oncol. 2018;25:2641.
   PubMed     Text format     Abstract available
   
   
7. LEE SY, Kim DW, Kang SI, Ihn MH, et al
   Impact of Family History on Prognosis of Patients with Sporadic Colorectal Cancer.
   Ann Surg Oncol. 2019 Jan 25. pii: 10.1245/s10434-019-07179.
   PubMed     Text format     Abstract available
   
   
8. YOMODA T, Sudo T, Kawahara A, Shigaki T, et al
   Correction to: The Immunoscore is a Superior Prognostic Tool in Stages II and III Colorectal Cancer and is Significantly Correlated with Programmed Death-Ligand 1 (PD-L1) Expression on Tumor-Infiltrating Mononuclear Cells.
   Ann Surg Oncol. 2019 Jan 29. pii: 10.1245/s10434-019-07208.
   PubMed     Text format     Abstract available
   
   

   
   BMC Gastroenterol

9. LEVY A, Borren NZ, Maxner B, Tan W, et al
   Cancer risk in microscopic colitis: a retrospective cohort study.
   BMC Gastroenterol. 2019;19:1.
   PubMed     Text format     Abstract available
   
   
10. CHANGXICHEN, Mao Y, Du J, Xu Y, et al
    Helicobacter pylori infection associated with an increased risk of colorectal adenomatous polyps in the Chinese population.
    BMC Gastroenterol. 2019;19:14.
    PubMed     Text format     Abstract available
    
    
11. SU J, Lai J, Yang R, Xu B, et al
    Capecitabine plus bevacizumab versus capecitabine in maintenance treatment for untreated characterised KRAS exon 2 wild-type metastatic colorectal cancer: a retrospective analysis in Chinese postmenopausal women.
    BMC Gastroenterol. 2019;19:17.
    PubMed     Text format     Abstract available
    
    

    
    Br J Cancer

12. FERNANDEZ-ROZADILLA C, Kartsonaki C, Woolley C, McClellan M, et al
    Telomere length and genetics are independent colorectal tumour risk factors in an evaluation of biomarkers in normal bowel.
    Br J Cancer. 2018;118:727-732.
    PubMed     Text format     Abstract available
    
    
13. DI GIROLAMO C, Walters S, Gildea C, Benitez Majano S, et al
    Which patients are not included in the English Cancer Waiting Times monitoring dataset, 2009-2013? Implications for use of the data in research.
    Br J Cancer. 2018;118:733-737.
    PubMed     Text format     Abstract available
    
    
14. PATEL M, McSorley ST, Park JH, Roxburgh CSD, et al
    The relationship between right-sided tumour location, tumour microenvironment, systemic inflammation, adjuvant therapy and survival in patients undergoing surgery for colon and rectal cancer.
    Br J Cancer. 2018;118:705-712.
    PubMed     Text format     Abstract available
    
    
15. MORGAN RG, Mortensson E, Legge DN, Gupta B, et al
    LGR5 expression is regulated by EGF in early colorectal adenomas and governs EGFR inhibitor sensitivity.
    Br J Cancer. 2018;118:558-565.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Lett

16. REN XL, Qiao YD, Li JY, Li XM, et al
    Cortactin recruits FMNL2 to promote actin polymerization and endosome motility in invadopodia formation.
    Cancer Lett. 2018;419:245-256.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

17. SCHIAPPACASSE COCIO GV, Schiappacasse ED
    Is Adjuvant Chemotherapy Efficient in Colon Cancer with High Microsatellite Instability? A Look Towards the Future.
    Cancer Res. 2019 Jan 24. pii: 0008-5472.CAN-18-2991.
    PubMed     Text format     Abstract available
    
    

    
    Clin Cancer Res

18. TOKUNAGA R, Xiu J, Johnston C, Goldberg RM, et al
    Molecular profiling of appendiceal adenocarcinoma and comparison with right-sided and left-sided colorectal cancer.
    Clin Cancer Res. 2019 Jan 28. pii: 1078-0432.CCR-18-3388.
    PubMed     Text format     Abstract available
    
    

    
    Clin Res Hepatol Gastroenterol

19. WANG W, Chen W, Lin J, Shen Q, et al
    Incidence and characteristics of young-onset colorectal cancer in the United States: An analysis of SEER data collected from 1988 to 2013.
    Clin Res Hepatol Gastroenterol. 2019 Jan 24. pii: S2210-7401(18)30184.
    PubMed     Text format     Abstract available
    
    

    
    Curr Treat Options Oncol

20. BREGNI G, Rebuzzi SE, Sobrero A
    The Optimal Duration of Adjuvant Therapy for Stage III Colon Cancer: the European Perspective.
    Curr Treat Options Oncol. 2019;20:8.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Cancer

21. MODEST DP, Pant S, Sartore-Bianchi A
    Treatment sequencing in metastatic colorectal cancer.
    Eur J Cancer. 2019;109:70-83.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Gastroenterol Hepatol

22. VAN DE WETERING AJP, Bogie RMM, Cabbolet ACOG, Winkens B, et al
    Update on the role of chromoendoscopy in colonoscopic surveillance of patients with Lynch syndrome.
    Eur J Gastroenterol Hepatol. 2018;30:1116-1124.
    PubMed     Text format     Abstract available
    
    
23. MUJTABA S, Bostick RM
    Differences in risk factor-colorectal adenoma associations according to non-steroidal anti-inflammatory drug use.
    Eur J Gastroenterol Hepatol. 2018;30:1318-1326.
    PubMed     Text format     Abstract available
    
    

    
    Gastroenterology

24. RANDEL KR, Botteri E, Romstad KMK, Frigstad SO, et al
    Effects of Oral Anticoagulants and Aspirin on Performance of Fecal Immunochemical Tests in Colorectal Cancer Screening.
    Gastroenterology. 2019 Jan 25. pii: S0016-5085(19)30103.
    PubMed     Text format     Abstract available
    
    
25. PUIG I, Lopez-Ceron M, Arnau A, Rosinol O, et al
    Accuracy of the Narrow-Band Imaging International Colorectal Endoscopic Classification System in Identification of Deep Invasion in Colorectal Polyps.
    Gastroenterology. 2019;156:75-87.
    PubMed     Text format     Abstract available
    
    
26. HORVAT N, Agaram NP, Gollub MJ
    Atypical Colonic Polyp.
    Gastroenterology. 2019;156:31-33.
    PubMed     Text format    
    
    
27. BORGERINK MMH, Weersma RK, Visschedijk MC
    A Case Report of a Young Adult With Progressive Bloody Diarrhea, Protein-Losing Enteropathy, and Extended Polyposis Coli.
    Gastroenterology. 2019;156:e10-e11.
    PubMed     Text format    
    
    

    
    Int J Cancer

28. ANTELO M, Golubicki M, Roca E, Mendez G, et al
    Lynch-like syndrome is as frequent as Lynch syndrome in early-onset non-familial non-polyposis colorectal cancer.
    Int J Cancer. 2019 Jan 29. doi: 10.1002/ijc.32160.
    PubMed     Text format     Abstract available
    
    
29. ABDUL-WAHID A, Cydzik M, Fischer NW, Prodeus A, et al
    Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cells.
    Int J Cancer. 2018;143:1963-1977.
    PubMed     Text format     Abstract available
    
    

    
    Int J Colorectal Dis

30. ABDEL-RAHMAN O, Ahmed O
    Predictors of toxicity-related hospitalization in four randomized studies of 5-fluorouracil-based chemotherapy in metastatic colorectal cancer.
    Int J Colorectal Dis. 2019 Jan 24. pii: 10.1007/s00384-019-03252.
    PubMed     Text format     Abstract available
    
    
31. SUN G, Li Y, Peng Y, Lu D, et al
    Impact of the preoperative prognostic nutritional index on postoperative and survival outcomes in colorectal cancer patients who underwent primary tumor resection: a systematic review and meta-analysis.
    Int J Colorectal Dis. 2019 Jan 24. pii: 10.1007/s00384-019-03241.
    PubMed     Text format     Abstract available
    
    

    
    Lancet

32. SUN R, Nie L, Huang B, Kim DH, et al
    Quantifying Immunoscore performance.
    Lancet. 2018;392:1624.
    PubMed     Text format    
    
    
33. PAGES F, Mlecnik B, Galon J
    Quantifying Immunoscore performance - Authors' reply.
    Lancet. 2018;392:1624-1625.
    PubMed     Text format    
    
    

    
    N Engl J Med

34. PROUTY M, Liu D
    Erythema Gyratum Repens Associated with Anal Cancer.
    N Engl J Med. 2019;380:e3.
    PubMed     Text format    
    
    

    
    Oncogene

35. KIM BR, Park SH, Jeong YA, Na YJ, et al
    RUNX3 enhances TRAIL-induced apoptosis by upregulating DR5 in colorectal cancer.
    Oncogene. 2019 Jan 28. pii: 10.1038/s41388-019-0693.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

36. RIOUX CR, Clapper ML, Cooper HS, Michaud J, et al
    Self-antigen MASH2 combined with the AS15 immunostimulant induces tumor protection in colorectal cancer mouse models.
    PLoS One. 2019;14:e0210261.
    PubMed     Text format     Abstract available
    
    
37. PIASECKI P, Narloch J, Brzozowski K, Ziecina P, et al
    The Predictive Value of SPECT/CT imaging in colorectal liver metastases response after 90Y-radioembolization.
    PLoS One. 2018;13:e0200488.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: